Kenn Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.35 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.35 M
- Revenue Growth 12.85%
- Profit Growth -0.45%
- Ebitda 146.45%
- Net Worth 0.57%
- Total Assets -7.26%
About Kenn Pharmaceuticals
Kenn Pharmaceuticals Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 September 2003 and has a history of 21 years and four months. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.35 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.35 M.
Mihul and Poonam Narad serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24200CH2003PTC026409
-
Company No.
026409
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Sep 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Kenn Pharmaceuticals Private Limited offer?
Kenn Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pharma & Bioanalytical Services, PCD Pharma Franchise, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Cardiovascular Drugs & Medication, Blood Pressure Medicine, Digestive System Drugs & Medicines, Pre & Probiotic Capsule.
Who are the key members and board of directors at Kenn Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Narad
|
Whole-Time Director | 13-Jan-2017 | Current |
|
Mihul
|
Director | 16-Jun-2014 | Current |
Financial Performance of Kenn Pharmaceuticals.
Kenn Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 12.85% increase. The company also saw a slight decrease in profitability, with a 0.45% decrease in profit. The company's net worth moved up by a moderate rise of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kenn Pharmaceuticals?
In 2019, Kenn Pharmaceuticals had a promoter holding of 10.00% and a public holding of 90.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹3.35 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 0.28 Cr
- Others : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2020 | Others | ₹0.55 M | Open |
| 16 Oct 2012 | Corporation Bank | ₹2.80 M | Open |
How Many Employees Work at Kenn Pharmaceuticals?
Unlock and access historical data on people associated with Kenn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kenn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenn Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
